Logo image of HIMS

HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis

NYSE:HIMS - New York Stock Exchange, Inc. - US4330001060 - Common Stock - Currency: USD

49.28  -17.13 (-25.79%)

After market: 49 -0.28 (-0.57%)

Fundamental Rating

5

Taking everything into account, HIMS scores 5 out of 10 in our fundamental rating. HIMS was compared to 108 industry peers in the Health Care Providers & Services industry. HIMS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. HIMS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

HIMS had positive earnings in the past year.
HIMS had a positive operating cash flow in the past year.
In the past 5 years HIMS reported 4 times negative net income.
HIMS had negative operating cash flow in 4 of the past 5 years.
HIMS Yearly Net Income VS EBIT VS OCF VS FCFHIMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

The Return On Assets of HIMS (16.81%) is better than 98.13% of its industry peers.
HIMS has a better Return On Equity (23.01%) than 92.52% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.89%, HIMS is in the better half of the industry, outperforming 76.64% of the companies in the same industry.
Industry RankSector Rank
ROA 16.81%
ROE 23.01%
ROIC 7.89%
ROA(3y)-16.29%
ROA(5y)-9.96%
ROE(3y)-20.03%
ROE(5y)-12.22%
ROIC(3y)N/A
ROIC(5y)N/A
HIMS Yearly ROA, ROE, ROICHIMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -10 -20 -30

1.3 Margins

HIMS has a Profit Margin of 8.15%. This is amongst the best in the industry. HIMS outperforms 88.78% of its industry peers.
The Operating Margin of HIMS (3.62%) is comparable to the rest of the industry.
HIMS's Gross Margin of 81.13% is amongst the best of the industry. HIMS outperforms 92.52% of its industry peers.
Industry RankSector Rank
OM 3.62%
PM (TTM) 8.15%
GM 81.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HIMS Yearly Profit, Operating, Gross MarginsHIMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40 60 80

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HIMS is destroying value.
The number of shares outstanding for HIMS has been increased compared to 1 year ago.
There is no outstanding debt for HIMS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HIMS Yearly Shares OutstandingHIMS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M 200M
HIMS Yearly Total Debt VS Total AssetsHIMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

HIMS has an Altman-Z score of 55.70. This indicates that HIMS is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 55.70, HIMS belongs to the top of the industry, outperforming 99.07% of the companies in the same industry.
HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 55.7
ROIC/WACC0.87
WACC9.06%
HIMS Yearly LT Debt VS Equity VS FCFHIMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

HIMS has a Current Ratio of 2.14. This indicates that HIMS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.14, HIMS is in the better half of the industry, outperforming 72.90% of the companies in the same industry.
A Quick Ratio of 1.82 indicates that HIMS should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.82, HIMS is doing good in the industry, outperforming 70.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 1.82
HIMS Yearly Current Assets VS Current LiabilitesHIMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 358.82% over the past year.
The Revenue has grown by 56.70% in the past year. This is a very strong growth!
EPS 1Y (TTM)358.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%900%
Revenue 1Y (TTM)56.7%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%77.13%

3.2 Future

Based on estimates for the next years, HIMS will show a very strong growth in Earnings Per Share. The EPS will grow by 72.47% on average per year.
HIMS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 28.52% yearly.
EPS Next Y596.09%
EPS Next 2Y158.51%
EPS Next 3Y102.97%
EPS Next 5Y72.47%
Revenue Next Year68.1%
Revenue Next 2Y53.59%
Revenue Next 3Y39.59%
Revenue Next 5Y28.52%

3.3 Evolution

HIMS Yearly Revenue VS EstimatesHIMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B
HIMS Yearly EPS VS EstimatesHIMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 112.00, the valuation of HIMS can be described as expensive.
HIMS's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 29.63, HIMS is valued quite expensively.
With a Price/Forward Earnings ratio of 95.67, HIMS can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, HIMS is valued a bit more expensive than 60.75% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.68. HIMS is valued rather expensively when compared to this.
Industry RankSector Rank
PE 112
Fwd PE 95.67
HIMS Price Earnings VS Forward Price EarningsHIMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

HIMS's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. HIMS is more expensive than 62.62% of the companies in the same industry.
HIMS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 71.96
EV/EBITDA 241.81
HIMS Per share dataHIMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HIMS's earnings are expected to grow with 102.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.19
PEG (5Y)N/A
EPS Next 2Y158.51%
EPS Next 3Y102.97%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HIMS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HIMS & HERS HEALTH INC

NYSE:HIMS (2/21/2025, 8:25:37 PM)

After market: 49 -0.28 (-0.57%)

49.28

-17.13 (-25.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)02-24 2025-02-24/amc
Inst Owners65.92%
Inst Owner Change19.43%
Ins Owners11.56%
Ins Owner Change5.75%
Market Cap10.77B
Analysts71.82
Price Target28.8 (-41.56%)
Short Float %31.67%
Short Ratio4.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)352.27%
Min EPS beat(2)37.66%
Max EPS beat(2)666.87%
EPS beat(4)4
Avg EPS beat(4)291.33%
Min EPS beat(4)37.66%
Max EPS beat(4)666.87%
EPS beat(8)7
Avg EPS beat(8)155.53%
EPS beat(12)9
Avg EPS beat(12)95.7%
EPS beat(16)11
Avg EPS beat(16)66.46%
Revenue beat(2)2
Avg Revenue beat(2)3.09%
Min Revenue beat(2)3%
Max Revenue beat(2)3.17%
Revenue beat(4)3
Avg Revenue beat(4)1.24%
Min Revenue beat(4)-2.07%
Max Revenue beat(4)3.17%
Revenue beat(8)6
Avg Revenue beat(8)1.45%
Revenue beat(12)10
Avg Revenue beat(12)3.73%
Revenue beat(16)13
Avg Revenue beat(16)-2.61%
PT rev (1m)3.36%
PT rev (3m)30.16%
EPS NQ rev (1m)-5.27%
EPS NQ rev (3m)11.21%
EPS NY rev (1m)-2.37%
EPS NY rev (3m)6.06%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)1.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.95%
Valuation
Industry RankSector Rank
PE 112
Fwd PE 95.67
P/S 8.67
P/FCF 71.96
P/OCF 57.67
P/B 24.47
P/tB 38.11
EV/EBITDA 241.81
EPS(TTM)0.44
EY0.89%
EPS(NY)0.52
Fwd EY1.05%
FCF(TTM)0.68
FCFY1.39%
OCF(TTM)0.85
OCFY1.73%
SpS5.68
BVpS2.01
TBVpS1.29
PEG (NY)0.19
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.81%
ROE 23.01%
ROCE 9.99%
ROIC 7.89%
ROICexc 18.14%
ROICexgc 93.35%
OM 3.62%
PM (TTM) 8.15%
GM 81.13%
FCFM 12.05%
ROA(3y)-16.29%
ROA(5y)-9.96%
ROE(3y)-20.03%
ROE(5y)-12.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover2.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 270.83%
Cap/Sales 2.98%
Interest Coverage 250
Cash Conversion 318.65%
Profit Quality 147.76%
Current Ratio 2.14
Quick Ratio 1.82
Altman-Z 55.7
F-Score7
WACC9.06%
ROIC/WACC0.87
Cap/Depr(3y)166.09%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)358.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%900%
EPS Next Y596.09%
EPS Next 2Y158.51%
EPS Next 3Y102.97%
EPS Next 5Y72.47%
Revenue 1Y (TTM)56.7%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%77.13%
Revenue Next Year68.1%
Revenue Next 2Y53.59%
Revenue Next 3Y39.59%
Revenue Next 5Y28.52%
EBIT growth 1Y222.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year613.95%
EBIT Next 3Y125.48%
EBIT Next 5Y73.97%
FCF growth 1Y615.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y914.6%
OCF growth 3YN/A
OCF growth 5YN/A